U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
127771127771Electrical Stimulation for Recovery of Hand Function in Chronic Stroke SurvivorsActive, not recruitingNo Results AvailableStroke|Hemiparesis|HemiplegiaDevice: Electrical stimulatorhttps://ClinicalTrials.gov/show/NCT00891319
127772127772Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient SubjectsCompletedNo Results AvailableFamilial Lipoprotein Lipase DeficiencyGenetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X]|Drug: mycophenolate mofetil|Drug: cyclosporine|Drug: methylprednisolonehttps://ClinicalTrials.gov/show/NCT00891306
127773127773A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™CompletedHas ResultsHypertriglyceridemiaDrug: Antara (fenofibrate) + Lovaza (omega-3-acid ethyl esters)https://ClinicalTrials.gov/show/NCT00891293
127774127774Dose-escalation Study of Oral CX-4945RecruitingNo Results AvailableAdvanced Solid Tumors|Breast Cancer|Inflammatory Breast Cancer|Castleman's Disease|Multiple MyelomaDrug: CX-4945 oral formulationhttps://ClinicalTrials.gov/show/NCT00891280
127775127775Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic SyndromeCompletedNo Results AvailableMetabolic Syndrome|HypertensionDrug: Olmesartan medoxomil tablets low dose|Drug: Olmesartan medoxomil tablets high dose|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00891267
127776127776Long-term Follow-up of Incisional Hernia Repaired With Intraperitoneal MeshCompletedNo Results AvailableIncisional HerniaDevice: Implant of a prosthetic meshhttps://ClinicalTrials.gov/show/NCT00891254
127777127777A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart FailureCompletedNo Results AvailableHeart FailureDrug: LMI 1195-101https://ClinicalTrials.gov/show/NCT00891241
127778127778Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal MenCompletedNo Results AvailableContraceptionDrug: Testosterone|Drug: Nestorone®|Drug: Nestorone®|Drug: Nestorone®https://ClinicalTrials.gov/show/NCT00891228
127779127779A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)Active, not recruitingHas ResultsGaucher Disease, Type 1Drug: Eliglustat tartrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00891202
127780127780Determine the Relationship Between Circadian Rhythms and Nocturnal AsthmaCompletedNo Results AvailableAsthmahttps://ClinicalTrials.gov/show/NCT00891189
127781127781Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib VaccinesCompletedHas ResultsNeisseria Meningitidis|Haemophilus Influenzae Type bBiological: MenitorixTM|Biological: Pneumococcal conjugate vaccine GSK1024850A|Biological: PrevenarTM|Biological: MeningitecTM|Biological: NeisVac-CTM|Biological: InfanrixTM hexa|Biological: InfanrixTM penta|Biological: InfanrixTM IPV/Hib|Biological: InfanrixTM IPVhttps://ClinicalTrials.gov/show/NCT00891176
127782127782Evaluate the Depth and Duration of AnesthesiaCompletedNo Results AvailablePainDrug: Syneraâ„¢ Topical Patch (70 mg lidocaine/70 mg tetracaine)|Drug: Placebo Patchhttps://ClinicalTrials.gov/show/NCT00891163
127783127783Oxytocin to Decrease Blood Loss During Cesarean SectionCompletedNo Results AvailableComplications; Cesarean SectionDrug: Oxytocinhttps://ClinicalTrials.gov/show/NCT00891150
127784127784Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCompletedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma|Plasma Cell Neoplasm|Myelodysplastic SyndromesBiological: human myeloid progenitor cellshttps://ClinicalTrials.gov/show/NCT00891137
127785127785Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).CompletedNo Results AvailableGlycemia|Hypertension|Hyperlipidemiahttps://ClinicalTrials.gov/show/NCT00891124
127786127786Incentives for Preventative Health Care: Increasing Completion of Health Risk AssessmentsNot yet recruitingNo Results AvailablePreventionBehavioral: Direct Payment|Behavioral: Regret Lotteryhttps://ClinicalTrials.gov/show/NCT00891111
127787127787Comparing Imaginal Exposure and Imagery Rescripting in Treatment of Posttraumatic Stress Disorder (PTSD)CompletedNo Results AvailablePosttraumatic Stress DisorderBehavioral: Imaginal exposure|Behavioral: Imagery rescriptinghttps://ClinicalTrials.gov/show/NCT00891098
127788127788Synchronized Intermittent Mechanical Ventilation Versus Open Lung Ventilation With Spontaneous RespirationRecruitingNo Results AvailableTraumahttps://ClinicalTrials.gov/show/NCT00891085
127789127789Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNo Results AvailableAdult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous StDrug: R-(-)-gossypol acetic acid|Drug: paclitaxel|Drug: carboplatin|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00891072
127790127790The Role Of Cognitive Impairment In The Use Of The Diskus InhalerCompletedNo Results AvailableCognitive Impairmenthttps://ClinicalTrials.gov/show/NCT00891059
127791127791An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and WCompletedNo Results AvailableSystemic Juvenile Idiopathic ArthritisDrug: Canakinumabhttps://ClinicalTrials.gov/show/NCT00891046
127792127792Panobinostat/Velcade in Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: Bortezomib (Velcade)|Drug: Panobinostathttps://ClinicalTrials.gov/show/NCT00891033
127793127793A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)CompletedHas ResultsRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]|Drug: tocilizumab [RoActemra/Actemra]|Drug: Nonbiologic DMARDs of investigator's choicehttps://ClinicalTrials.gov/show/NCT00891020
127794127794Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 YearsCompletedNo Results AvailableMeaslesBiological: MVA-mBN85B|Biological: MVA-mBN85B|Biological: Rouvaxhttps://ClinicalTrials.gov/show/NCT00891007
127795127795Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)Enrolling by invitationNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00890994
127796127796A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With DenosumabCompletedHas ResultsLow Bone Mass|Low Bone Mineral Density|Osteoporosis|Postmenopausal OsteoporosisProcedure: high-resolution peripheral quantitative computed tomography (HR-pQCT)|Procedure: Dual energy X-ray absorptiometry (DXA)|Biological: Denosumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00890981
127797127797Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand DermatitisCompletedNo Results AvailableHand DermatosesDrug: Triamcinolone Acetonide (TAC) DuraPeel|Drug: Placebo DuraPeelhttps://ClinicalTrials.gov/show/NCT00890968
127798127798Amrubicin + Cyclophosphamide in Advanced Solid Organ MalignanciesCompletedNo Results AvailableLung CancerDrug: Amrubicin|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00890955
127799127799Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean SectionCompletedNo Results AvailableMorphine Adverse ReactionDrug: naloxone|Drug: normal salinehttps://ClinicalTrials.gov/show/NCT00890942
127800127800Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)CompletedHas ResultsAcute Myeloid Leukemia (AML)|Adult Acute Myeloblastic LeukemiaDrug: Lenalidomide|Drug: Azacitidinehttps://ClinicalTrials.gov/show/NCT00890929

* Görseller ve İçerik tekif hakkına sahip olabilir